WINKELRIED JON
SEC CIK 1366946 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| SION | Sionna Therapeutics, Inc. | 10% | 6.49M | — | $10.00M | 1 | 2026-01-22 | 2026-01-22 |
| TPG | TPG Inc. | CEO, Dir, 10% | 2.87M | — | $43.76M | 15 | 2023-01-13 | 2026-01-13 |
| BETA | BETA Technologies, Inc. | Former 10% Owner | 16.40M | — | — | 1 | 2025-11-05 | 2025-11-05 |
| LTH | Life Time Group Holdings, Inc. | Former 10% Owner | 21.40M | — | $245.16M | 1 | 2025-06-06 | 2025-06-06 |
| NRDY | Nerdy Inc. | Former Dir, 10% Owner | 8.07M | — | — | 1 | 2024-11-12 | 2024-11-12 |
| LFST | LifeStance Health Group, Inc. | 10% | 160.71M | — | $85.84M | 1 | 2024-05-24 | 2024-05-24 |
| NXT | Nextpower Inc. | 10% | 6.04M | — | $622.60M | 2 | 2024-02-05 | 2024-02-05 |
| SLE | Super League Enterprise, Inc. | 10% | 8.59M | — | $255.8K | 9 | 2023-06-06 | 2023-07-20 |
| PGNY | Progyny, Inc. | 10% | 9.25M | — | $29.06M | 1 | 2022-11-07 | 2022-11-07 |
| TRVI | Trevi Therapeutics, Inc. | Former 10% Owner | 3.82M | — | $2.76M | 2 | 2022-06-29 | 2022-07-01 |
Most active insiders at SION, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Thompson Peter A. | Dir | — | $55.67M |
| 2 | ORBIMED ADVISORS LLC | Dir | — | $52.73M |
| 3 | RA CAPITAL MANAGEMENT, L.P. | Dir, 10% | — | $27.34M |
| 4 | Booth Bruce | Dir | — | $22.09M |
| 5 | RA Capital Nexus Fund III, L.P. | Dir | — | $14.76M |
| 6 | WINKELRIED JON | 10% | — | $10.00M |
| 7 | Cloonan Michael | Pres, CEO, Dir | — | $5.13M |
| 8 | OrbiMed Capital GP VIII LLC | Dir | — | $2.95M |
| 9 | Fitzpatrick Jennifer | CLO, Head of Program Mgmt | — | $1.21M |
| 10 | Kolchinsky Peter | Dir, 10% | — | $1.20M |
Transactions 34
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| I | 2026-01-26 | 2026-01-22 | SION | Sionna Therapeutics, Inc. | WINKELRIED JON | 10% | S - Sale | $40.00 | -250.0K | 6.49M | -4% | -$10.00M |
| D | 2026-01-15 | 2026-01-13 | TPG | TPG Inc. | WINKELRIED JON | CEO, Dir, 10% | F - Tax | $66.03 | -415.7K | 2.87M | -13% | -$27.45M |
| D | 2026-01-15 | 2026-01-13 | TPG | TPG Inc. | WINKELRIED JON | CEO, Dir, 10% | M - OptEx | — | +583.8K | 3.96M | +17% | — |
| D | 2026-01-15 | 2026-01-13 | TPG | TPG Inc. | WINKELRIED JON | CEO, Dir, 10% | A - Grant | — | +499.5K | 3.37M | +17% | — |
| 2025-11-21 | 2025-11-19 | TPG | TPG Inc. | WINKELRIED JON | CEO, Dir | G - Gift | $0.00 | -239.0K | 3.29M | -7% | $0 | |
| DI | 2025-11-07 | 2025-11-05 | BETA | BETA Technologies, Inc. | WINKELRIED JON | Former 10% Owner | C - Cnv Deriv | — | +16.40M | 16.40M | New | — |
| I | 2025-06-10 | 2025-06-06 | LTH | Life Time Group Holdings, Inc. | WINKELRIED JON | Former 10% Owner | S - Sale | $29.38 | -8.34M | 21.40M | -28% | -$245.16M |
| D | 2025-01-15 | 2025-01-13 | TPG | TPG Inc. | WINKELRIED JON | CEO, Dir, 10% | M - OptEx | — | +583.8K | 3.53M | +20% | — |
| D | 2025-01-15 | 2025-01-13 | TPG | TPG Inc. | WINKELRIED JON | CEO, Dir, 10% | A - Grant | — | +122.6K | 2.95M | +4% | — |
| D | 2025-01-15 | 2025-01-13 | TPG | TPG Inc. | WINKELRIED JON | CEO, Dir, 10% | F - Tax | $62.40 | -404.0K | 2.82M | -13% | -$25.21M |
| 2024-12-02 | 2024-11-27 | TPG | TPG Inc. | WINKELRIED JON | CEO, Dir, 10% | G - Gift | $0.00 | -100.0K | 3.23M | -3% | $0 | |
| I | 2024-11-14 | 2024-11-12 | NRDY | Nerdy Inc. | WINKELRIED JON | Former Dir, 10% Owner | J - Other | $0.00 | -2.76M | 8.07M | -25% | $0 |
| I | 2024-05-29 | 2024-05-24 | LFST | LifeStance Health Group, Inc. | WINKELRIED JON | 10% | S - Sale | $5.89 | -14.57M | 160.71M | -8% | -$85.84M |
| DMI | 2024-02-29 | 2024-02-29 | TPG | TPG Inc. | WINKELRIED JON | CEO, Dir | S - Sale+OE | $41.64 | -50.8K | 0 | -100% | -$2.12M |
| D | 2024-02-29 | 2024-02-27 | TPG | TPG Inc. | WINKELRIED JON | CEO, Dir | M - OptEx | $0.00 | +1.00M | 4.33M | +30% | $0 |
| D | 2024-02-29 | 2024-02-29 | TPG | TPG Inc. | WINKELRIED JON | CEO, Dir | S - Sale+OE | $41.64 | -1.00M | 3.33M | -23% | -$41.64M |
| DI | 2024-02-07 | 2024-02-05 | NXT | Nextpower Inc. | WINKELRIED JON | 10% | S - Sale | $56.60 | -11.00M | 6.04M | -65% | -$622.60M |
| DI | 2024-02-07 | 2024-02-05 | NXT | Nextpower Inc. | WINKELRIED JON | 10% | C - Cnv Deriv | — | +4.28M | 17.04M | +34% | — |
| D | 2024-01-17 | 2024-01-13 | TPG | TPG Inc. | WINKELRIED JON | CEO, Dir, 10% | F - Tax | $39.52 | -45.1K | 3.18M | -1% | -$1.78M |
| D | 2024-01-17 | 2024-01-13 | TPG | TPG Inc. | WINKELRIED JON | CEO, Dir, 10% | A - Grant | — | +143.1K | 3.33M | +4% | — |
| D | 2023-12-04 | 2023-11-30 | TPG | TPG Inc. | WINKELRIED JON | CEO, Dir, 10% | A - Grant | — | +2.59M | 3.23M | +409% | — |
| MI | 2023-07-24 | 2023-07-20+ | SLE | Super League Enterprise, Inc. | WINKELRIED JON | 10% | S - Sale | $0.35 | -18.1K | 8.59M | -0.2% | -$6,342 |
| MI | 2023-07-18 | 2023-07-14+ | SLE | Super League Enterprise, Inc. | WINKELRIED JON | 10% | S - Sale | $0.3672 | -117.3K | 8.64M | -1% | -$43.1K |
| MI | 2023-07-05 | 2023-06-30 | SLE | Super League Enterprise, Inc. | WINKELRIED JON | 10% | S - Sale | $0.4 | -1,900 | 9.10M | -0.0% | -$760 |
| MI | 2023-06-30 | 2023-06-28+ | SLE | Super League Enterprise, Inc. | WINKELRIED JON | 10% | S - Sale | $0.4 | -14.1K | 9.10M | -0.2% | -$5,646 |
| MI | 2023-06-28 | 2023-06-26+ | SLE | Super League Enterprise, Inc. | WINKELRIED JON | 10% | S - Sale | $0.4 | -84.5K | 9.14M | -0.9% | -$33.8K |
| I | 2023-06-21 | 2023-06-16 | SLE | Super League Enterprise, Inc. | WINKELRIED JON | 10% | S - Sale | $0.54 | -6,876 | 9.20M | -0.1% | -$3,713 |
| MI | 2023-06-14 | 2023-06-12+ | SLE | Super League Enterprise, Inc. | WINKELRIED JON | 10% | S - Sale | $0.5636 | -44.0K | 9.31M | -0.5% | -$24.8K |
| MI | 2023-06-12 | 2023-06-08+ | SLE | Super League Enterprise, Inc. | WINKELRIED JON | 10% | S - Sale | $0.54 | -71.0K | 9.34M | -0.8% | -$38.3K |
| MI | 2023-06-08 | 2023-06-06+ | SLE | Super League Enterprise, Inc. | WINKELRIED JON | 10% | S - Sale | $0.5731 | -173.3K | 9.46M | -2% | -$99.3K |
| 2023-01-18 | 2023-01-13 | TPG | TPG Inc. | WINKELRIED JON | CEO, Dir, 10% | A - Grant | — | +294.8K | 633.7K | +87% | — | |
| I | 2022-11-09 | 2022-11-07 | PGNY | Progyny, Inc. | WINKELRIED JON | 10% | S - Sale | $38.75 | -750.0K | 9.25M | -8% | -$29.06M |
| MI | 2022-07-06 | 2022-07-01+ | TRVI | Trevi Therapeutics, Inc. | WINKELRIED JON | Former 10% Owner | S - Sale | $2.89 | -500.0K | 3.82M | -12% | -$1.45M |
| MI | 2022-07-01 | 2022-06-29+ | TRVI | Trevi Therapeutics, Inc. | WINKELRIED JON | 10% | S - Sale | $2.77 | -476.0K | 4.75M | -9% | -$1.32M |
Purchase Sale Sale after option exercise All abbreviations